VidistarViewer vs Clinidence
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
VidistarViewer
Access and review medical images, videos, and diagnostic reports instantly on your mobile device. Enhance patient understanding by showing them their studies directly. Supports various diagnostic DICOM studies for comprehensive review.
- Instant access to medical images and reports
- View still images and video clips
- Review diagnostic DICOM studies
- Access patient information
- Review studies from any location
- Patient engagement tool
Read full descriptionHide full description
VidistarViewer™ offers medical professionals instant access to their medical images and reports from their mobile Apple device(s). With VidistarViewer™, users may view still images, video clips, patient information, diagnostic reports, and review their diagnostic DICOM studies (i.e. echos, vascular studies, OBGYN, nuclear, cath, angio, etc.). Review Studies from Anywhere VidistarViewer™ includes similar functionality to VidiStar's web-solutions, and allows users to review studies and reports regardless of location. Engage Your Patients Use your iPad to show your patient their diagnostic study and enhance their engagement in their plan of care by educating them on their condition, thus heightening their understanding and furthering your patient-relationship.
Clinidence
Read full descriptionHide full description
Stay current in 5 minutes a week — without the noise. Clinidence reads the week's new medical literature for your specialty and turns it into a short stack of cards you can swipe through over coffee. Every card leads with the one thing that matters: what the study found, how big the effect is, and whether it should change your practice. WHAT MAKES IT DIFFERENT • Verified to source. Each card's key quote is checked, word-for-word, against the original PubMed abstract — so you're never reading an AI's paraphrase. If it can't be verified, we don't show it. • Study type, up front. Every card is labeled by design — RCT, meta-analysis, systematic review, guideline, or observational — so you know how much weight to give it at a glance. • The number that matters. When the effect size and confidence interval are in the source, we surface them (e.g. HR 0.74, 95% CI 0.61–0.89) — pulled straight from the verified text, never invented. • A weekly briefing. Open the app to a one-line read on the week — "8 papers, 2 practice-changing" — then dive into the cards. • Honest about AI. Impact and evidence grades are clearly labeled as AI assessment, grounded in study design — not dressed up as peer review. HOW IT WORKS 1. Pick your specialty (22 supported). 2. Each week, get a curated digest of the newest, highest-quality papers. 3. Swipe up to save, down to skip, tap for the full breakdown — PICO, limitations, and a one-tap link to PubMed. 4. Save cards to a personal library and share a clean, citable card with a colleague. BUILT FOR PRACTICING CLINICIANS No paywalls on the science. No engagement-bait. Just the evidence, structured the way you actually appraise it. Clinidence is an informational tool for licensed healthcare professionals. It summarizes published research and is not medical advice; always use your clinical judgment and consult primary sources.
Screenshots
Verdict
The clearest difference is iOS requirement: VidistarViewer at 13.0 against Clinidence's 18.0. On price, ads, in-app purchases and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
| Parameter | VidistarViewer | Clinidence |
|---|---|---|
| Price | Free | Free |
| Rating | 3.0 (2 ratings) — better | — |
| Positive reviews | 50.0% of reviews | — |
| Number of ratings | 2 — better | — |
| Update frequency | Every 30 months | — |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | — |
| Devices | iPhone, iPad, iPod — better | iPhone, iPad |
| Requires iOS | 13.0 — better | 18.0 |
| Further details — not scored | ||
| Size | 1 MB | 4 MB |
| Age rating | 17+ | 4+ |
| Developer | VidiStar, LLC | Nasser Ibrahim |
In-app purchases
VidistarViewer
No in-app purchases
Clinidence
No in-app purchases









